CRT 2025

Technology and Innovation

BRS DES and DCB Technologies

5-year FU of the COMPARE-ABSORB Trial and Update on the Ongoing 7-Year FU

Speaker(s)

• 

  Pieter C. Smits, PhD, FESC

  Chief Medical Director
  CERC (Cardiovascular European Research Center)
  Rotterdam, Zuid-Holland, Netherlands

  Disclosure information not submitted.